We hypothesized that FLI of bombesin and transferrin receptor expression can be used for early detection of treatment-induced tumor metabolic changes in a manner similar to the gold standard of 18F-FDG PET imaging [28]. The gene discussed is TFRC; the disease is neoplasm.